<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1727">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1727">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1728">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1728">Condensed Consolidated Balance Sheets (March 31, 2020 unaudited)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1729">Condensed Consolidated Balance Sheets (March 31, 2020 unaudited) - Parenthetical</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1730">Unaudited Condensed Consolidated Statement of Operations</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1731">Unaudited Condensed Consolidated Statements of Cash Flows</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1732">Unaudited Condensed Consolidated Statements of Cash Flows - Supplemental Disclosure of Non-Cash Investing and Financing Activities</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1733">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1733">Note 1 - Basis of Presentation</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1734">Note 2 - Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1735">Note 3 - Property and Equipment</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1736">Note 4 - Due to Related Party</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1737">Note 5 - Loan Payable, Related Parties</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1738">Note 6 - Convertible Debt</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1739">Note 7 - Stockholders' Deficit</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1740">Note 8 - Commitments and Contingencies</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1741">Note 9 - Related Party Transactions</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1742">Note 10 - Subsequent Events</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1743">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1743">Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1744">Note 2 - Summary of Significant Accounting Policies: Accounting Estimates (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1745">Note 2 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1746">Note 2 - Summary of Significant Accounting Policies: Property and Equipment (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1747">Note 2 - Summary of Significant Accounting Policies: Debt Issuance Costs (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1748">Note 2 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1749">Note 2 - Summary of Significant Accounting Policies: Shipping and Handling Costs (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1750">Note 2 - Summary of Significant Accounting Policies: Research and Development (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1751">Note 2 - Summary of Significant Accounting Policies: Stock Based Compensation (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1752">Note 2 - Summary of Significant Accounting Policies: Loss Per Share (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1753">Note 2 - Summary of Significant Accounting Policies: Advertising (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1754">Note 2 - Summary of Significant Accounting Policies: Concentrations of Credit Risk (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1755">Note 2 - Summary of Significant Accounting Policies: Reclassifications (Policies)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1756">Note 2 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1757">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1757">Note 2 - Summary of Significant Accounting Policies: Stock Based Compensation: Schedule of Fair Value of Warrants (Tables)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1758">Note 3 - Property and Equipment: Schedule of Property and Equipment (Sptember 30 2019 Unaudted) (Tables)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1759">Note 6 - Convertible Debt: Schedule of Convertible Debt (Sptember 30 2019 unaudited) (Tables)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1760">Note 7 - Stockholders' Deficit: Schedule of Status of Warrants (Tables)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1761">Note 7 - Stockholders' Deficit: Schedule of Warrants outstanding and exercisable by price range (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1762">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1762">Note 1 - Basis of Presentation (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1763">Note 2 - Summary of Significant Accounting Policies: Debt Issuance Costs (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1764">Note 2 - Summary of Significant Accounting Policies: Revenue Recognition (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1765">Note 2 - Summary of Significant Accounting Policies: Stock Based Compensation (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1766">Note 2 - Summary of Significant Accounting Policies: Stock Based Compensation: Schedule of Fair Value of Warrants (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1767">Note 2 - Summary of Significant Accounting Policies: Loss Per Share (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1768">Note 2 - Summary of Significant Accounting Policies: Advertising (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1769">Note 3 - Property and Equipment: Schedule of Property and Equipment (Sptember 30 2019 Unaudted) (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1770">Note 3 - Property and Equipment (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1771">Note 5 - Loan Payable, Related Parties: Christopher Maggiore (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1772">Note 5 - Loan Payable, Related Parties: HEP Investments, LLC (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1773">Note 6 - Convertible Debt: Schedule of Convertible Debt (Sptember 30 2019 unaudited) (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1774">Note 6 - Convertible Debt (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1775">Note 7 - Stockholders' Deficit: Board of Directors fees (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1776">Note 7 - Stockholders' Deficit: Stock Issuances (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1777">Note 7 - Stockholders' Deficit (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1778">Note 7 - Stockholders' Deficit: Schedule of Status of Warrants (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1779">Note 7 - Stockholders' Deficit: Schedule of Warrants outstanding and exercisable by price range (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1780">Note 10 - Subsequent Events: Loan Payable - Related Party (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1781">Note 10 - Subsequent Events: Paycheck Protection Program Loan (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1782">Note 10 - Subsequent Events: Stock Issuances (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1783">Note 10 - Subsequent Events: License Co-Development Participation Agreement (Details)</a></li>
                                                            <li><a href="https://ir.zivobioscience.com/all-sec-filings/xbrl_doc_only/1784">Note 10 - Subsequent Events: Financial Consulting Agreement (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Note 2 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)</h4>
                <div style="clear:both;"></div>
    </div>
</div>

<link rel="stylesheet" href="//ir.zivobioscience.com/stylesheets/xbrl.css" type="text/css">